According to the latest report published by Data Bridge Market Research, the Duchenne Muscular Dystrophy Market The global Duchenne Muscular Dystrophy market size was valued at USD 1.10 billion in 2025 and is expected to reach USD 2.78 billion by 2033, at a CAGR of 12.30% during the forecast period The market research studies of Duchenne Muscular Dystrophy Market business report...

Gene therapy clinical progress creating paradigm shift — delandistrogene moxeparvovec (SRP9001/Eteplirsen GT) and other AAV-based gene therapy approaches — delivering functional dystrophin gene directly into muscle tissue enabling sustained dystrophin expression without repeated antisense oligonucleotide administration — representing fundamentally different therapeutic...